Do biological alterations precede the onset of psychosis? A systematic review and meta-analysis of immune, cardiometabolic, prolactin and HPA axis alterations in clinical high-risk for psychosis
Por:
Aymerich C, Pedruzo B, Salazar de Pablo G, Labad J, McCutcheon R, Pillinger T, González-Torres MÁ, Sanchez-Gistau V, Oliver D, Alonso-Alconada D, Navalón P, Sugranyes G, Vieta E, Arango C, McGuire P, Fusar-Poli P and Catalan A
Publicada:
1 ago 2025
Ahead of Print:
1 abr 2025
Resumen:
First episode psychosis (FEP) individuals show biological abnormalities preceding antipsychotic treatment. However, it remains unclear whether such alterations are also present before the onset of psychosis. We aim to provide estimates of standardized mean differences for immune, cardiometabolic, prolactin, and HPA axis parameters in individuals at clinical high-risk for psychosis (CHR-P) compared to healthy controls (HC) and FEP individuals, and between CHR-P transitioning to psychosis (CHR-T) compared non-transitioning (CHR-NT). A multistep literature search was performed from database inception until September 25, 2023. PRISMA/MOOSEcompliant and pre-registered (PROSPERO: CRD42024507670) systematic review identified studies reporting on immune, cardiovascular or endocrine parameters in CHR-P samples compared with HC or FEP samples or comparing CHR-T vs CHR-NT. Inter-group differences in magnitude of effect were estimated using Hedges g and estimates were pooled using random-effects meta-analysis. Heterogeneity was high for most outcomes. 37 studies were included, total sample 2509 CHR-P, 710 FEP, and 1444 HC individuals. A statistically significant elevation of pro-inflammatory proteins was found among CHR-P compared with HC (k = 12; N = 1710; g = 0.16; p < 0.01) and FEP (k = 7; g = 0.15; p = 0.04) subjects. Interleukin-6 (IL-6) was increased in CHR-P compared to HC (k = 9; N = 1243; g = 0.54; p < 0.01), and interleukin-4 (IL-4) was increased in CHR-T compared with CHR-NT (k = 2; N = 318; g = 0.36; p < 0.01). CHR-P exhibited stronger cortisol awakening response than FEP subjects (k = 3; N = 173; g = 0.51; p = 0.01). CHR-P and FEP individuals did not show statistically significant differences in terms of prolactin levels. An inflammatory state (particularly marked by elevated IL-6 and IL-4 levels) and HPA axis alterations are present in CHR-P individuals.
Filiaciones:
Aymerich C:
Psychiatry Department, Basurto University Hospital, Biobizkaia Health Research Institute, OSI Bilbao-Basurto, University of the Basque Country, Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Bilbao, Spain
Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
Pedruzo B:
Psychiatry Department, Basurto University Hospital, Biobizkaia Health Research Institute, OSI Bilbao-Basurto, University of the Basque Country, Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Bilbao, Spain
Salazar de Pablo G:
Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón School of Medicine, Universidad Complutense, IiSGM, Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, Spain
Child and Adolescent Mental Health Services, South London and Maudsley NHS Foundation Trust, London, UK
:
Department of Mental Health, Consorci Sanitari del Maresme, Mataró, Institut de Neurociències, Translational Neuroscience Research Unit I3PT-INc-UAB, Institut d'Investigació I Innovació Parc Taulí (I3PT), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain
McCutcheon R:
Department of Psychiatry, University of Oxford, Oxford Health NHS Foundation Trust, Oxford, UK
Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, London, UK
Oxford Health NHS Foundation Trust, Oxford, UK
Pillinger T:
Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London. London, UK
González-Torres MÁ:
Psychiatry Department, Basurto University Hospital, Biobizkaia Health Research Institute, OSI Bilbao-Basurto, University of the Basque Country, Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Bilbao, Spain
Sanchez-Gistau V:
Hospital Universitari Institut Pere Mata of Reus, Reus, Spain
Institut d'Investigació Sanitària Pere Virgili (IISPV-CERCA), Tarragona, Spain
Universitat Rovira i Virgili (URV), Reus, Spain
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Reus, Spain
Oliver D:
Department of Psychiatry, University of Oxford, NIHR Oxford Health Biomedical Research Centre. Oxford, UK
Alonso-Alconada D:
Department of Cell Biology and Histology, School of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain
Navalón P:
Department of Psychiatry and Clinical Psychology, La Fe University and Polytechnical Hospital, Valencia, Spain
Mental Health Research Unit, Health Research Institute La Fe, Valencia, Spain
Sugranyes G:
Department of Child and Adolescent Psychiatry and Psychology, 2021SGR01319, Hospital Clínic de Barcelona. Fundació de Recerca Clínic Barcelona, Institut d'Investigacions Biomèdiques Agustí Pi I Sunyer (IDIBAPS). Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
Vieta E:
Department of Child and Adolescent Psychiatry and Psychology, 2021SGR01319, Hospital Clínic de Barcelona. Fundació de Recerca Clínic Barcelona, Institut d'Investigacions Biomèdiques Agustí Pi I Sunyer (IDIBAPS). Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain
Arango C:
Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón School of Medicine, Universidad Complutense, IiSGM, Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Madrid, Spain
McGuire P:
Department of Psychiatry, University of Oxford, Oxford Health NHS Foundation Trust. NIHR Oxford Health Biomedical Research Centre, Oxford, UK
Fusar-Poli P:
Early Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, King's College London, London, UK
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
Outreach and Support in South-London (OASIS) Service, South London and Maudsley (SLaM) NHS Foundation Trust, London, UK
Department of Psychiatry and Psychotherapy, University Hospital, Ludwig-Maximilian-University (LMU), Munich, Germany
Catalan A:
Psychiatry Department, Basurto University Hospital, Biobizkaia Health Research Institute, OSI Bilbao-Basurto, University of the Basque Country, Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Bilbao, Spain
Department of Psychiatry, University of Oxford, Oxford Health NHS Foundation Trust, Oxford, UK
Green Published, hybrid
|